EncapX® presented to the AFSSI life sciences community
8 July 2026
Biotech One presented EncapX® to the AFSSI life sciences community. EncapX® is a continuous millifluidic platform designed to encapsulate active ingredients in nanoliposomes and LNPs precisely, reproducibly and at scale. The platform is designed to carry encapsulation from R&D to production scale.
Related news
Biotech One joins ETPN, the European Technology Platform on Nanomedicine
A European network of researchers, biotech companies and industrial partners. New collaborations, and nanoencapsulation closer to clinical needs.
4 November 2026
Biotech One joins France BioLead
Contributing to French biomanufacturing. EncapX® brings a continuous approach to nanoparticle, nanoliposome and LNP formulation.
26 June 2026
Biotech One joins AFSSI Sciences de la Vie
Biotech One joins AFSSI Sciences de la Vie, the French association of companies partnering in preclinical research, development and health innovation.
11 June 2026